
|Videos|July 28, 2016
Incorporating Newer Antiemetics in Clinical Practice
Advertisement
Episodes in this series

James Natale, PharmD, BCOP, explains the importance of understanding newer antiemetic options in the changing therapeutic landscape of chemotherapy-induced nausea and vomiting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
4
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
5
















































































































































